雷国强 1谢士茂 2陈木娟 1白玉 1李冬影 1陈桂红1
作者信息
- 1. 广东医学院附属西乡人民医院，广东 深圳 518102
- 2. 广东省深圳市宝安区计划生育专科医院，广东 深圳 518101
- 折叠
摘要
Abstract
Objective To investigate the cost effective theraPy for allergic rhinitis- asthma syndrome,from the Point of view of Pharma-ceutical economics,to choose the reasonable treatment of drug. Methods 280 cases of allergic rhinitis-astlma syndrome Patients were equally divided into glucocorticoid grouP(A),the anti histamine grouP(B),leukotriene recePtor antagonist grouP(C),anti-IgE monoclonal antibody grouP(D),transfer factor grouP(E),glucocorticoid add transfer factor grouP (F) and glucocorticoid add anti-IgE monoclonal antibody grouP(G) dePending on the drug aPPlication resPectively,each with aPProPriate medication. Results The effective rates of grouP D,E,F and G were higher than grouP A,B,C( P < 0. 05);the cost of grouP C,D,F and G were significantly higher than grouP A,B,E( P < 0. 05),the C/ E values of grouP A,B and E were significantly less than the other grouPs( P < 0. 05). Conclusion The method of glucocorticoid law,the anti histamine and the transfer factor are the best treatment for treating allergic rhinitis-asthma syndrome.关键词
过敏性鼻炎-哮喘综合征/成本-效果/药物经济学/糖皮质激素/抗组胺/转移因子Key words
allergic rhinitis-asthma syndrome/cost-effectiveness/Pharmaceutical economics/glucocorticoids/anti-histamine/transfer factor分类
医药卫生
